Y.N. Vashisht Gopal

3.8k total citations
25 papers, 1.8k citations indexed

About

Y.N. Vashisht Gopal is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Y.N. Vashisht Gopal has authored 25 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 7 papers in Organic Chemistry and 6 papers in Oncology. Recurrent topics in Y.N. Vashisht Gopal's work include Melanoma and MAPK Pathways (10 papers), Cancer therapeutics and mechanisms (5 papers) and Histone Deacetylase Inhibitors Research (4 papers). Y.N. Vashisht Gopal is often cited by papers focused on Melanoma and MAPK Pathways (10 papers), Cancer therapeutics and mechanisms (5 papers) and Histone Deacetylase Inhibitors Research (4 papers). Y.N. Vashisht Gopal collaborates with scholars based in United States, India and Australia. Y.N. Vashisht Gopal's co-authors include Michael A. Davies, Michael W. Van Dyke, Anand K. Kondapi, Scott E. Woodman, Wanleng Deng, Gordon B. Mills, Paul D. Smith, Prahlad T. Ram, Kakajan Komurov and Grant M. Fischer and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Biochemistry.

In The Last Decade

Y.N. Vashisht Gopal

25 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Y.N. Vashisht Gopal United States 18 1.2k 872 366 261 243 25 1.8k
Chandra Bartholomeusz United States 24 1.2k 1.0× 867 1.0× 416 1.1× 321 1.2× 166 0.7× 44 2.0k
Ahmed A. Samatar United States 14 1.3k 1.0× 629 0.7× 249 0.7× 141 0.5× 116 0.5× 31 1.7k
Edward Rosfjord United States 19 938 0.8× 1.0k 1.2× 271 0.7× 383 1.5× 182 0.7× 39 1.9k
Jeffrey H. Chen United States 6 1.0k 0.8× 520 0.6× 207 0.6× 353 1.4× 361 1.5× 7 1.6k
Jonas Cicenas Switzerland 17 921 0.7× 684 0.8× 383 1.0× 254 1.0× 108 0.4× 28 1.5k
J.M. Ostrem United States 6 1.9k 1.5× 818 0.9× 225 0.6× 301 1.2× 254 1.0× 8 2.4k
James Tsai United States 16 1.1k 0.9× 757 0.9× 185 0.5× 238 0.9× 218 0.9× 27 1.8k
Lacey E. Dobrolecki United States 21 1.4k 1.1× 891 1.0× 412 1.1× 245 0.9× 204 0.8× 53 2.3k
Kenna Anderes United States 18 1.8k 1.4× 576 0.7× 218 0.6× 111 0.4× 210 0.9× 46 2.3k
Melanie Valenti United Kingdom 30 1.7k 1.3× 1.1k 1.2× 302 0.8× 197 0.8× 383 1.6× 61 2.6k

Countries citing papers authored by Y.N. Vashisht Gopal

Since Specialization
Citations

This map shows the geographic impact of Y.N. Vashisht Gopal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y.N. Vashisht Gopal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y.N. Vashisht Gopal more than expected).

Fields of papers citing papers by Y.N. Vashisht Gopal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Y.N. Vashisht Gopal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y.N. Vashisht Gopal. The network helps show where Y.N. Vashisht Gopal may publish in the future.

Co-authorship network of co-authors of Y.N. Vashisht Gopal

This figure shows the co-authorship network connecting the top 25 collaborators of Y.N. Vashisht Gopal. A scholar is included among the top collaborators of Y.N. Vashisht Gopal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Y.N. Vashisht Gopal. Y.N. Vashisht Gopal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wilson, Emily, Aaron Rogers, Zongzhong Tong, et al.. (2024). Tumour-intrinsic endomembrane trafficking by ARF6 shapes an immunosuppressive microenvironment that drives melanomagenesis and response to checkpoint blockade therapy. Nature Communications. 15(1). 6613–6613. 5 indexed citations
2.
Yuan, Ping, Da Teng, Man Li, et al.. (2023). Loss of AMPKα2 promotes melanoma tumor growth and brain metastasis. iScience. 26(6). 106791–106791. 9 indexed citations
3.
Tan, Lin, Barbara Knighton, Mary Sobieski, et al.. (2022). Combined inhibition of HMGCoA reductase and mitochondrial complex I induces tumor regression of BRAF inhibitor-resistant melanomas. SHILAP Revista de lepidopterología. 10(1). 6–6. 14 indexed citations
4.
Williams, Leila J., Courtney W. Hudgens, Grant M. Fischer, et al.. (2020). The Glutaminase Inhibitor CB-839 (Telaglenastat) Enhances the Antimelanoma Activity of T-Cell–Mediated Immunotherapies. Molecular Cancer Therapeutics. 20(3). 500–511. 112 indexed citations
5.
Gammon, Seth T., Federica Pisaneschi, Madhavi Bandi, et al.. (2019). Mechanism-Specific Pharmacodynamics of a Novel Complex-I Inhibitor Quantified by Imaging Reversal of Consumptive Hypoxia with [18F]FAZA PET In Vivo. Cells. 8(12). 1487–1487. 20 indexed citations
6.
Gopal, Y.N. Vashisht, Helen Rizos, Guo Chen, et al.. (2014). Inhibition of mTORC1/2 Overcomes Resistance to MAPK Pathway Inhibitors Mediated by PGC1α and Oxidative Phosphorylation in Melanoma. Cancer Research. 74(23). 7037–7047. 148 indexed citations
7.
Chen, Guo, Nitin Chakravarti, Kimberly Aardalen, et al.. (2014). Molecular Profiling of Patient-Matched Brain and Extracranial Melanoma Metastases Implicates the PI3K Pathway as a Therapeutic Target. Clinical Cancer Research. 20(21). 5537–5546. 120 indexed citations
8.
Mao, Muling, Feng Tian, John M. Mariadason, et al.. (2012). Resistance to BRAF Inhibition in BRAF-Mutant Colon Cancer Can Be Overcome with PI3K Inhibition or Demethylating Agents. Clinical Cancer Research. 19(3). 657–667. 235 indexed citations
9.
Gopal, Y.N. Vashisht, et al.. (2011). Role and therapeutic potential of PI3K‐mTOR signaling in de novo resistance to BRAF inhibition. Pigment Cell & Melanoma Research. 25(2). 248–258. 79 indexed citations
10.
Gopal, Y.N. Vashisht, Wanleng Deng, Scott E. Woodman, et al.. (2010). Basal and Treatment-Induced Activation of AKT Mediates Resistance to Cell Death by AZD6244 (ARRY-142886) in Braf- Mutant Human Cutaneous Melanoma Cells. Cancer Research. 70(21). 8736–8747. 177 indexed citations
11.
Gopal, Y.N. Vashisht, et al.. (2009). Parthenolide promotes the ubiquitination of MDM2 and activates p53 cellular functions. Molecular Cancer Therapeutics. 8(3). 552–562. 68 indexed citations
12.
Woodman, Scott E., Jonathan C. Trent, Katherine Stemke‐Hale, et al.. (2009). Activity of dasatinib against L576P KIT mutant melanoma: Molecular, cellular, and clinical correlates. Molecular Cancer Therapeutics. 8(8). 2079–2085. 141 indexed citations
13.
Davies, Michael A., Katherine Stemke‐Hale, E. Lin, et al.. (2009). Integrated Molecular and Clinical Analysis of AKT Activation in Metastatic Melanoma. Clinical Cancer Research. 15(24). 7538–7546. 159 indexed citations
14.
Gopal, Y.N. Vashisht, et al.. (2007). Parthenolide Specifically Depletes Histone Deacetylase 1 Protein and Induces Cell Death through Ataxia Telangiectasia Mutated. Chemistry & Biology. 14(7). 813–823. 91 indexed citations
15.
Pickering, Brian F., et al.. (2007). Constitutive and inducible nuclear factor-κB in immortalized normal human bronchial epithelial and non-small cell lung cancer cell lines. Cancer Letters. 255(1). 85–94. 17 indexed citations
16.
Gopal, Y.N. Vashisht, et al.. (2005). Tumour necrosis factor‐α depletes histone deacetylase 1 protein through IKK2. EMBO Reports. 7(3). 291–296. 30 indexed citations
17.
Gopal, Y.N. Vashisht & Michael W. Van Dyke. (2003). Combinatorial Determination of Sequence Specificity for Nanomolar DNA-Binding Hairpin Polyamides. Biochemistry. 42(22). 6891–6903. 18 indexed citations
18.
Gopal, Y.N. Vashisht, et al.. (2002). Topoisomerase II antagonism and anticancer activity of coordinated derivatives of [RuCl2(C6H6)(dmso)]. Archives of Biochemistry and Biophysics. 401(1). 53–62. 42 indexed citations
19.
Gopal, Y.N. Vashisht, et al.. (2000). Topoisomerase II Poisoning and Antineoplastic Action by DNA-Nonbinding Diacetyl and Dicarboxaldoxime Derivatives of Ferrocene. Archives of Biochemistry and Biophysics. 376(1). 229–235. 35 indexed citations
20.
Gopal, Y.N. Vashisht, et al.. (1999). Topoisomerase II Is a Cellular Target for Antiproliferative Cobalt Salicylaldoxime Complex. Archives of Biochemistry and Biophysics. 369(1). 68–77. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chandra Bartholomeusz Breakdown of academic impact, for papers by Ahmed A. Samatar Breakdown of academic impact, for papers by Edward Rosfjord Breakdown of academic impact, for papers by Jeffrey H. Chen Breakdown of academic impact, for papers by Jonas Cicenas Breakdown of academic impact, for papers by J.M. Ostrem Breakdown of academic impact, for papers by James Tsai Breakdown of academic impact, for papers by Lacey E. Dobrolecki Breakdown of academic impact, for papers by Kenna Anderes Breakdown of academic impact, for papers by Melanie Valenti
Rankless by CCL
2026